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Abstract 
We have tested the ability of Amphotericin B to form ion channels/defects in osmotically stressed large unilamellar vesicles (LUV) 
using pyranine fluorescence detected ion/H + exchange. We found that sterol-free LUV exhibit greatly increased sensitivity to AraB 
channel formation in the soluble oligomer state (> 0.5 /zM) under modestly hypoosmotic conditions (< 100 amosM). These vesicles are 
completely insensitive under isoosmotic onditions. The related antibiotics, Amphotericin B methyl ester and Nystatin showed almost no 
activity under hypoosmotic conditions in the absence of sterol. This difference may be attributable to differences in solution oligomeric 
states. Experiments with KCI and CaC12 internal buffers demonstrate hat these sterol-free AmB membrane disruptions are highly 
selective for monovalent cations (K +) over anions (CI-), ruling out massive lysis or unselective membrane defects caused by osmotic 
pressure. Thus, AmB seems to be acting as a 'molecular harpoon', an expression coined to describe substances which can selectively 
target osmotically stressed, strained or highly curved membranes. These results may provide a rationale for AmB's reported anti-HIV 
activity and reported activity against sterol-free small unilamellar vesicles (highly curved membranes) aswell as the reduced activity of 
liposomal drug delivery systems toward cholesterol-containing a dsterol-free membranes (fewer soluble oligomers). 
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I. Introduction 
Amphotericin B (AmB) is a very effective membrane- 
active antibiotic used to fight systemic fungal infections. 
Unfortunately, AmB has a low therapeutic index due to 
toxic side effects of current preparations (see [1] and 
references therein). Despite this, AmB still remains the 
drug of choice against most serious systemic fungal infec- 
tions. The selectivity toward fungi presumably rests in the 
selective interaction of AmB with ergosterol in fungi 
versus cholesterol in mammalian cell membranes. 
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Abbreviations: AmB, Amphotericin B; LUV, large unilamellar vesi- 
cle(s); SUV, small unilamellar vesicle(s); Mops, 3-(N-morpholino)pro- 
panesulfonic acid; FCCP, carbonyl cyanide p-(trifluoromethoxy)phenyl- 
hydrazone; EPC, egg phosphatidylcholine; AmE, amphotericin B-methyl 
ester; Ny, Nystatin. 
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Research as been conducted to determine the mode of 
action and the active species of AmB ([2,3] and references 
within) with the goal of increasing its therapeutic index 
and to better understand the nature of the channel forming 
complex. Recent work suggests that AraB is especially 
toxic toward cholesterol-containing vesicles and mam- 
malian cells when in a soluble oligomeric state which has 
B.D. Wolf S.C. Hartsel/ Biochimica et Biophysica Acta 1238 (1995) 156-162 157 
a characteristic excitonic CD spectrum. This structure may 
also attack membranes in a sterol independent manner 
[4-6]. Several less toxic AmB liposomal drug delivery 
mixtures have been developed and tested and these seem 
to work by reducing the amount of this free oligomeric 
AmB in solution though the precise structure of this active 
oligomer is still unknown [7-9]. 
Related work suggests that some membrane-active drugs 
and newly synthesized amphiphilic agents may be acting 
as 'molecular harpoons'. This term was introduced by 
Regen and co-workers to describe their synthetic am- 
phiphilic molecules which recognize osmotic stress in lipid 
bilayers because of their hydrophobic wedge-shaped tips. 
These molecules insert disruptively when the lipid packing 
density of the outer monolayer is reduced by internal 
swelling caused by osmotic pressure [10-15]. The struc- 
ture and selectivity of these defects is unknown but they 
can cause channel-like leakage rather than total lysis. Like 
AmB, these substances' activities are strongly dependent 
upon their oligomerization state and the presence of sterols 
in the membrane. 
These similarities uggest hat it is possible that AmB 
also acts in this manner [13]. If AmB or its oligomers can 
indeed act as molecular harpoons, sterol free LUV might 
be expected to experience an increased sensitivity to AraB 
under hypoosmotic onditions due to pressure-induced 
splaying of the outer monolayer. A similar increase in 
activity could help explain the ability of AmB to induce 
channels in the absence of sterol in egg phosphatidyl- 
choline (EPC) small sonicated unilamellar vesicles (SUV, 
r~ 150 ~,) since such vesicles have a small radius of 
curvature and experience a 'looseness' in the external 
bilayer leaflet similar to that produced by internal osmotic 
pressure [16]. Activity against sterol-free large unilamellar 
vesicles (LUV, r > 500 A) is not observed even at very 
high AmB concentrations [17,18]. In this report we test the 
hypothesis that AmB can act as a molecular harpoon and 
that its activity depends upon its oligomerization state and 
the magnitude of the osmotic gradient. 
2. Materials and methods 
2.1. Materials 
Egg phosphatidylcholine (EPC) was isolated from fresh 
egg yolks by using the Singleton procedure [19]. Purified 
Amphotericin B and Nystatin were generous gifts from 
Bristol-Myers Squibb Pharmaceuticals (Princeton, NJ). 
Amphotericin B-methyl ester was a generous gift from 
Professor Jacques Bolard. FCCP (carbonyl cyanide p-(tri- 
fluoromethoxy)phenylhydrazone) was obtained from Sigma 
(St. Louis, MO). Valinomycin, a K ÷ ionophore and 4- 
bromo-A23187, a Ca 2+ ionophore, were purchased from 
CalBiochem (La Jolla, CA). Laser-grade pyranine (1,3,6- 
pyrenetrisulfonic a id) was purchased from Eastman-Kodak 
(Rochester, NY). 
2.2. Preparation and assay of lipid cesicle samples 
Lipids in chloroform were dried by an argon stream and 
vacuum desiccated for approx. 1 h to remove chloroform. 
The lipids were dispersed in 25 mM Mops buffer, pH 7.20 
with either 100 mM K2504, 100 mM KC1 or 50 mM 
CaCI 2 solution with 2.2 mM pyranine (internal buffers) 
except where indicated. Freeze-thawed lipid dispersions 
were extruded 10x through a I000 A Nucleopore filter 
using the Extruder (Lipex, Vancouver BC). External pyra- 
nine was removed by gel filtration through an internal 
buffer equilibrated column of Sephadex G-25. Following 
separation, 5 /xM FCCP was added to vesicles to allow for 
free exchange of H + ions. An instantaneous salt (KCI, 
K2SO 4, CaC12) and osmolality gradient was created by 
diluting the vesicles with variable ratio stopped flow sy- 
tinges to a 6:1 ratio. Osmotic gradients were established by 
mixing the isoosmotic sucrose 25 mM Mops, pH 7.20 
buffer with an identical buffer without sucrose and deter- 
mining osmolarity. The osmolarity of the buffer/vesicle 
solutions was monitored using an automatic osmometer 
(/zOsmette, Precision Systems, Natick, MA). AraB and 
AmE and Ny were introduced to the sucrose/Mops dilut- 
ing buffer from DMSO stock solutions made up to 1.3 
raM, 1.4 mM and 1.3 mM, respectively. The initial os- 
motic difference (see Discussion) between the vesicle lu- 
men and external medium is expressed as _AmosM, 
where a positive sign indicates inside hyperosmotic. 
2.3. Measurement of K +, C1-, and net ion currents in 
LUV 
Ion currents were measured with an On Line Instrument 
Systems (OL1S, Jefferson, GA) converted Durrum D-110 
stopped-flow spectrophotometer in the fluorescence mode. 
Stopped-flow techniques for measuring ion currents using 
the pH sensitive dye pyranine as a reporter molecule have 
been developed over the past few years and the concentra- 
tions, instrumentation, data handling and interpretation a d 
other experimental conditions were identical to those in 
Hartsel et al. [18] with the main difference being that 1000 
diameter extruded LUV were used in vesicle studies 
instead of sonicated vesicles. For the current studies, 25 
mM Mops pH 7.20 with 100 mM K2SO 4 or KCI or 50 
mM CaC12 was rapidly diluted with a hypoosmotic sucrose 
solution/25 mM Mops, pH 7.20 external buffer in a 
temperature controlled stopped flow fluorimeter (22°__+ 
2°C). The final total lipid concentration was 1-3 mM. Our 
assay measures pH changes inside the LUV that result 
from the AmB induced K + currents when sulfate is the 
counter ion (sulfate is not permeant) and net current when 
CI- is the counterion since CI- may be permeant to a 
lesser degree depending upon the conditions [20]. With the 
incorporation of the protonophore FCCP into the LUV 
bilayers, H ÷ can equilibrate rapidly across the membrane. 
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Hence, the imposed salt gradients coupled with the 
ionophoric action of AraB cause a H + for K + (or C1-) 
exchange that is limited by the rate of AraB induced K + or 
C1- effiux. The pyranine molecules entrapped in the target 
LUV provide a sensitive fluorescence assay for detecting 
interior vesicular pH changes. The initial rate of pH change 
induced by AmB was used for comparisons of AraB's 
channel activity under different osmotic conditions and is 
expressed in ApH s - I  [6,18,21,22]. The points represent 
the average initial slope of three trials + 1 S.D. 
3. Results 
The pyranine fluorescence detected ion current method 
employed here has proven useful in detecting AraB-in- 
duced ion currents under isoosmotic salt gradient condi- 
tions [6,18,21]. However, interpreting electrogenic K + or 
CI- currents by fluorescence changes under hypoosmotic 
conditions might pose some problems due to the possible 
significant osmotic swelling, lysis and/or internal dilution 
of LUV due to water influx under these conditions [23]. 
As a test for the reliability of this method we created 
KCI gradients in opposite directions under hypoosmotic 
pressure gradients and treated the sterol free EPC LUV 
with valinomycin, If this method works qualitatively under 
these conditions, we would expect opposite fluorescence 
changes. In fact Fig. 1 (a + g) shows good qualitative and 
quantitative agreement for valinomycin activity although 
not surprisingly, due to differences in ionic strength, the 
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Fig. 1. Time-course plot of the change in pH resulting from electrogenic 
K + ion current from sterol-free EPC vesicles with oppositely oriented 
KC1 gradients. Leakage induced by (a) 0.025 ftM valinomycin, (b) 0.025 
p~M valinomycin and 10.0 p~M AraB, and (c) 5.0 /~M AraB in EPC 
vesicles containing 350 mM sucrose, 22.5 mM KC1, and 25 mM Mops, 
pH 7.20 diluted with 100 mM KC1 to produce an osmotic gradient of 
+ 186 AmosM. Traces of (d) 0.5 /~M AraB, (e) 5.0 ~LM AraB, (f) 5.0 
/~M AraB and 0.05 btM valinomycin, and (g) 0.05 p~M valinomycin were 
added to EPC vesicles with 100 mM KCl diluted by 40 mM sucrose to 
produce a + 113 AmosM gradient. The direction of the fluorescence 
change in each case shows that K + > C1- selective channels are formed 
by Arab in the presence of an osmotic gradient and also demonstrates 
that treated vesicles can maintain a potential, thus ruling out significant 
LUV lysis. 
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Fig. 2. Comparison of the initial pH change induced by 5.0 ftM AraB 
(0) ,  5.0 /~M AmE (v ) ,  5.0 /.tM Nystatin (rq) on sterol-free LUV 
containing 100 mM K2SO 4 under various initial osmolarity gradients. 
The zero point which had an equivalent ionic, hut no osmotic, gradient 
was indistinguishable from the baseline. 
kinetics are different. In addition, Fig. 1 demonstrates that 
at these AmosM the vesicles are sensitive to AmB in the 
absence of sterol, and again, show opposite changes in 
fluorescence indicating K+> C1- selectivity. This study 
(see Fig. 2) as well as past studies have shown that AmB 
under isoosmotic onditions hows no membrane activity 
on sterol free LUV under these concentrations [ 17,18]. 
In all other experiments, the K + ionophore valinomycin 
was added with the highest [AmB] as a control to ensure 
that significant vesicle osmotic lysis and/or pyranine loss 
was not occurring, i.e., to determine whether the vesicles 
could maintain a stable diffusion potential. In no case was 
catastrophic rupture of the vesicles observed. In addition, 
if vesicle lysis were occurring, pyranine would be released 
into the external solution. As an additional control, ~ 2 
mg/ml  vesicle dispersions at high +AmosM were ex- 
posed to 10 /zM AraB for 10 min and run again through a 
Sephadex G-25 gel column. Qualitatively, there were no 
signs of the highly fluorescent external pyranine retained 
on the column (data not shown); i.e., there was complete 
retention of pyranine associated with the vesicle fraction. 
Since AraB in aqueous buffer solution can adopt at least 
three types of aggregate structures (see Discussion), we 
tried to determine whether it was a soluble species or 
insoluble aggregate (an inactive species against red blood 
cells) which was the major contributor to observed ion 
currents. A 2.0 p~M (final diluted concentration) AmB 
dilution buffer was made from either a 0.1 mM AmB DMF 
or a 1.3 mM DMSO stock solution. The final solution of 
AraB from DMF is expected to be virtually free of the 
insoluble aggregate [4] whereas that made from the DMSO 
stock should have an appreciable insoluble aggregate com- 
ponent (est. 20-30%; Ref. [4]). Using these solutions, an 
initial + 148 AosM gradient was imposed upon sterol free 
LUV with 100 mM K2SO 4 inside. Within the standard 
error of these measurements, identical currents were gener- 
ated by these two preparations, indicating that the insolu- 
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ble aggregate form is not a necessary species for osmotic 
recognition ( ( -2 .9  + 0.9). 10 -4 ApH/s  for DMSO and 
( -2 .7  + 1.0)- 10 -4 ApH/s  for DMF). It is surprising that 
these currents are so similar in that the buffer made from 
the DMF stock should have relatively more of the soluble 
oligomer form. However, considering the difference in 
buffer composition and temperature (22°C vs. 37°C) from 
Ref. [4], perhaps the solution from DMSO stock has a 
greater soluble ol igomer and lesser monomer component 
(see also temperature dependence in [6]). These data com- 
bined with the observed 0.5 /zM threshold for non-sterol 
dependent activity strongly suggests that the soluble aggre- 
gate/o l igomer form is the species which recognizes os- 
motic stress. 
Fig. 2 illustrates the effect of increasing osmotic gradi- 
ents on the activity of 5.0 /~M AmB, AmE, and Nystatin 
on sterol-free LUV in K2SO 4 buffer. There is an increase 
in the initial rate of K + current as the internal vesicle 
pressure increases at constant AraB concentration as probed 
by fluorescence detected H+/K  ÷ exchange. A substantial 
increase in K + permeability is not observed for AmE and 
Ny until higher internal pressures are attained and still the 
rate is far less than that of AmB. In the absence of an 
osmotic differential, the fluorescence trace is indistinguish- 
able from the baseline. 
The pH detected initial rate of K ÷ leakage increases as 
the AraB concentration i creases at constant osmotic pres- 
sure difference with a constant K2SO 4 gradient (Fig. 3) in 
the presence of LUV containing 10 mol% cholesterol or no 
sterol. Notice, however, that there is approx, a 30-fold 
higher leakage rate at a given [AmB] for the cholesterol- 
containing EPC vesicles relative to sterol free. 
In the presence of KCI gradients AmB always produced 
a K + selective response. Figs. 1 and 4 demonstrate he K ÷ 
over C1- selectivity of the osmotic pressure enhanced 
AmB channels. In Fig. 4 a decrease in fluorescence 
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duced permeability for C1 not only under isoosmotic 
conditions but under osmotic stress (Fig. 4 and [18,20]). 
4. Discussion 
Based on ultrastructure and trapped volume measure- 
ments Mui et al. [23] showed that extruded 1:1 choles- 
terol/egg phosphatidylcholine v sicles may be ellipsoidal 
rather than spherical and may swell up to + 50% more 
trapped volume under slight osmotic gradients. It is not 
known whether this 'rounding up' process adds to osmotic 
strain on the bilayer or whether the results are applicable 
to pure egg phosphatidylcholine or 10% cholesterol LUV 
used in most of the present experiments with AmB. Other 
studies on osmotically active LUV vesicles composed of 
pure phospholipid (dioleoylphosphatidylglycerol) showed 
that osmotic stress and strain increased with applied os- 
motic gradients and could be satisfactorily modeled by 
assuming polydispersity and a maximal swelling of only 
6% [24,25]. Other studies on extruded LUV of similar size 
and composition to ours have show that these vesicles are 
osmotically active and swell up with accompanying os- 
motic membrane stress up to an osmotic gradient of about 
AmosM -= + 200 [12]. After this point, size stays relatively 
the same while residual osmotic pressure continually in- 
creases to a point where solute leakage/rupture occurs. A 
common feature of all of these studies was that significant 
osmotic lysis/leakage of untreated membrane vesicles as 
measured by carboxyfluorescein leakage did not occur 
before about +400-500 AmosM, well above the modest 
gradients in the current measurements. 
The most serious concern to the current study with 
reference to these prior results is the possibility that osmot- 
ically induced rounding up could cause a significant dilu- 
tion of the LUV lumen osmolality without accompanying 
increases in membrane osmotic stress or strain [23]. For 
our experiments, we calculated that even if the maximal 
swelling reported in [23] occurred (+ 50%) without any 
added stress, all of our measurements, with the exception 
of the lowest (+ 54 AmosM points) in Fig. 2, would still 
have significant residual osmotic gradients (from 30-55% 
of predicted) and hence osmotic strain. The fact that the 
+54 AmosM point does show measurable sensitivity to 
AmB probably indicates that some osmotic strain does 
indeed occur upon rounding up or that these vesicles are 
more nearly spherical. In any case, due to this unsettled 
question of the swelling factor in LUV, all osmotic gradi- 
ents are reported as init ial gradients. 
There has been much interest recently in the effect of 
the association state, structure and physical nature of the 
bilayer target on the membrane activity of drugs, peptides 
and synthetic surfactants. Regen and co-workers has shown 
that certain amphipathic ompounds with a wedge or 
harpoon shape can selectively insert (as monomers gener- 
ally) into osmotically stressed membranes and cause leak- 
age but not necessarily rupture [11,12]. In these cases, 
cholesterol seems to relatively enhance osmotic stress sen- 
sitivity [12]. In addition, the non-ionic detergent, Triton 
X-100 was shown to cause a slow leakage of trapped 
solutes in LUV when introduced in the monomeric state 
(< cmc) and massive catastrophic lysis when introduced 
from the micellar state against gel phase vesicles while 
leakage pathways dominate in fluid vesicles [13]. The 
membrane activity of various classes of membrane active 
agents in these and other studies (cf. [26,27]) was mea- 
sured by the extent of the leakage of the self quenching 
dye carboxyfluorescein, which does not offer insight into 
the microscopic nature and organization of these 
channel/defects. The current studies have the advantage of 
being able to gain more specific information as to the 
molecular nature of channels induced in osmotically 
stressed environments by looking at the ionic selectivity. 
At least three distinct forms of AmB can coexist in 
aqueous preparations: the monomeric, soluble oligomer, 
and insoluble aggregate. The relative occurrence of these 
forms is complicated epending upon [AmB], time, tem- 
perature, stock solvent and stock concentration, and buffer 
composition [4-6]. It has been suggested that only the 
soluble oligomeric form of AraB is active against choles- 
terol containing and sterol free membranes. Under the 
conditions of these experiments and stocks, the soluble 
oligomeric form of Arab begins to predominate at about 
0.5 /xM [6]. This is also the concentration at which the 
osmotically stressed sterol-free vesicles become sensitive. 
Nystatin, a topical antifungal drug with a similar structure 
to AmB, does not aggregate below a 10 /xM concentration 
[5] and accordingly it shows almost no activity in our 
experiments (Fig. 2). Thus, it seems that the soluble 
oligomer and/or insoluble aggregate is the principal active 
species recognizing osmotic stress. Since our experiments 
using different stock solvents suggests no major effect 
from the insoluble aggregate species, it is highly likely that 
the soluble oligomer is the main osmotically active species. 
This conclusion is in excellent agreement with results on a 
tethered oligomeric surfactant vs. its monomeric ounter- 
part synthesized by Regen and co-workers [11]. In this 
case, the tethered oligomer showed a significant stress 
induced carboxyfluorescein leakage yet had almost no 
effect on isoosmotic LUV. In contrast the monomer showed 
only slightly enhanced activity in response to osmotic 
stress. It is interesting that AME also shows little activity 
in light of the fact that it should be self-associated at the 
concentrations used in Fig. 2 [5]. However, the much 
higher water solubility of the cationic AME as compared 
to zwitterionic AmB and Ny may explain this lack of 
effect. Perhaps this is also related to the relatively lower 
acute toxicity of AME toward mammalian cells. 
In agreement with studies on molecular harpoon surfac- 
tants [12], the presence of cholesterol enhanced the relative 
sensitivity of osmotically stressed vesicles to AraB as 
shown in Fig, 3, but unlike these harpoons, cholesterol also 
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enhances AraB sensitivity under isoosmotic onditions. It 
is likely that the specific association and interactions of 
AmB in both monomeric and oligomeric states with 
cholesterol complicates interpretation of molecular har- 
poon action under these circumstances. 
In the present study, we have shown that AmB can act 
as an exquisitely sensitive molecular harpoon. But what 
then is the active oligomeric structure and why does it act 
as a molecular harpoon? Based on CD, theoretical and 
NMR interpretation it has been speculated that the anti- 
parallel dimer may be the fundamental unit of aggregation 
for AmB in solutions [5,28-31]. The calculated/experi-  
mental antiparallel dimer turns out to be very similar in 
structure to the X-ray diffraction unit cell of the iodo-AmB 
derivative [32]. It has been recently noted that the crystal 
structure dimer of AmB has a remarkably polar and apolar 
face like the membrane disruptive amphiphilic 'rafts' pro- 
posed for some membrane active helical peptides (see Fig. 
2 in Refs, [2,33]). Using Quanta generated CPK models we 
have estimated that the hydrophobic surface of the anti- 
para!lel dimer is large and rectangular with an estimated 
1 1 A X 24 A span and a shallow triangular cross-section 
with the polyene at the apex. In contrast, the monomer 
could conceivably bind to a membrane by insertion of the 
heptaene chain, presenting a hydrophobic surface only 3.1 
A wide which would not be nearly so disruptive. Based on 
this model it would not be surprising that an oligomer with 
such a large hydrophobic surface should selectively target 
( 'harpoon')  osmotically stressed membranes with their 
more accessible hydrophobic acyl chain interiors. 
These results also help explain the previously puzzling 
results on the strong activity of AmB on sterol free SUV 
and the total lack of activity of Ny on similar vesicles 
[16,21]. SUV produced by sonication have a small radius 
( r= 150 ,~) creating a similar outer monolayer stress 
condition as that of vesicles under osmotic stress where the 
hydrophobic region of the phospholipid becomes more 
exposed. This is also a reasonable xplanation for the 
increased binding affinity and higher binding rate of AmB 
and derivatives for sterol free SUV vs. sterol free LUV 
[17,34]. We would expect that other surfactants demon- 
strating selective activity for osmotically stressed mem- 
branes would also show enhanced activity against SUV. 
Experiments are currently underway to determine whether 
osmotic stress enhanced AmB binding to LUV is the 
mechanism of this molecular harpoon type activity. A 
natural situation where such a small radius of curvature 
like an SUV is observed is the outer lipid membrane of 
various envelope viruses such as HIV. The reported anti- 
HIV activity of AmB and some of its derivatives may be a 
consequence of this curvature [35,36]. 
One of the most remarkable findings of this study is 
that, contrary to expectations that rather nonselective mem- 
brane disruption would be observed, the AmB channels 
induced by osmotic stress are highly monovalent cation 
selective even in the absence of sterol. While it is clear 
that sterols, especially ergosterol, can interact directly with 
AmB in the channel formation process (see [3,4] and 
references therein), sterols are not necessary to produce 
highly cation selective AmB channels'. Thus, it seems that 
osmotic stress induced changes in the lipid bilayer may 
actually 'catalyze' the formation and assembly of AmB 
channel structures within the vesicle membrane. It will be 
interesting to assess whether other osmotically sensitive 
surfactants may also produce more defined channel struc- 
tures than previously thought. 
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